Detalhe da pesquisa
1.
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial.
Ann Oncol
; 28(2): 270-277, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28426106
2.
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials.
Ann Oncol
; 27(11): 2103-2110, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27601237
3.
Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.
Curr Oncol
; 23(3): 196-200, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27330348
4.
Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel.
Br J Cancer
; 113(1): 20-9, 2015 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26035702
5.
A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1).
Ann Oncol
; 26(8): 1741-8, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25997818
6.
Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors.
Curr Oncol
; 21(6): 329-36, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25489260
7.
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.
Ann Oncol
; 24(2): 314-321, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23123509
8.
Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer.
Ann Oncol
; 24(9): 2390-6, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23842283
9.
Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL).
Ann Oncol
; 21(9): 1804-1809, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20150572
10.
The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statement.
Curr Oncol
; 16(1): 27-48, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19229369
11.
Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancer.
Curr Oncol
; 26(1): 37-42, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853796
12.
Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancer.
Curr Oncol
; 26(1): e81-e93, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853813
13.
Irreversible tyrosine kinase inhibition of epidermal growth factor receptor with afatinib in EGFR activating mutation-positive advanced non-small-cell lung cancer.
Curr Oncol
; 25(Suppl 1): S9-S17, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29910643
14.
Breaking the biomarker code: PD-L1 expression and checkpoint inhibition in advanced NSCLC.
Cancer Treat Rev
; 65: 65-77, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567557
15.
Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.
Curr Oncol
; 25(5): 317-328, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30464681
16.
Thoracic irradiation in 3weeks for limited-stage small cell lung cancer: Is twice a day fractionation really needed?
Cancer Radiother
; 21(2): 89-98, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28325618
17.
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
J Clin Oncol
; 7(8): 993-1002, 1989 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-2547030
18.
Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.
J Clin Oncol
; 18(6): 1351-9, 2000 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-10715308
19.
Imaging of small cell carcinoma using 131I-labelled antibodies to vasopressin associated human neurophysin (VP-HNP)
Nucl Med Commun
; 10(9): 643-52, 1989 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-2559381
20.
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29.
Eur J Cancer
; 50(4): 706-12, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24360368